Announcements
26 January 2025
World Neglected Tropical Diseases Day—30 January 2025
On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.
We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
“A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System”
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568
“Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria”
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047
“Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview”
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050
“Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review”
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203
“Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review”
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205
“False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report”
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100
“Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks”
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022
“Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission”
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014
“Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study”
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425
“DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction”
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624
“Global Fight against Malaria: Goals and Achievements 1900–2022”
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680
“Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil”
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469
“Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice”
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128
“Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective”
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285
“Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming”
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015
“Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania”
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658
|
Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition” |
Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases” |
|
|
|
|
Special Issue: “One Health and Neglected Zoonotic Diseases” |
Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota” |
|
|
|
21 January 2025
Acknowledgment to the Reviewers of Pharmaceuticals in 2024
21 January 2025
MDPI’s Newly Launched Journals in December 2024
Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.
We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.
Please feel free to browse and discover more about the new journals below.
| Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
|
|
Prof. Dr. Zhaoyang Dong |
energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage View journal scope | Submit an article |
 |
Prof. Dr. Yang-Hui He 1. London Institute for Mathematical Sciences, Royal Institution, UK 2. University of Oxford, UK Editorial | View inaugural issue |
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory; convex geometry View journal scope | Submit an article |
 |
Dr. Michel Planat Université de Franche-Comté, France Editorial | View inaugural issue |
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets View journal scope | Submit an article |
 |
Prof. Dr. Rashid Al Abri 1. Sultan Qaboos University, Oman 2. Oman Medical Association, Oman Editorial | View inaugural issue |
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety View journal scope | Submit an article |
 |
Prof. Dr. Ecevit Bilgili* New Jersey Institute of Technology, USA *Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration. Editorial | View inaugural issue |
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production View journal scope | Submit an article |
 |
Dr. Weiyong Liu Huazhong University of Science and Technology, China Editorial | View inaugural issue |
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry View journal scope | Submit an article |
 |
Prof. Dr. Manuel Pedro Rodríguez Bolívar University of Granada, Spain Editorial | View inaugural issue |
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation View journal scope | Submit an article |
 |
Prof. Dr. Fei Fan Wuhan University, Wuhan 430072, China Editorial | View inaugural issue |
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice View journal scope | Submit an article |
 |
Dr. Kevin Cianfaglione Université Catholique de Lille, France Editorial | View inaugural issue |
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation View journal scope | Submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
17 January 2025
Meet Us at the 145th Annual Meeting of the Pharmaceutical Society of Japan, 26–29 March 2025, Fukuoka, Japan
7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reflecting on 2024: Celebrating Our Progress and People
As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.
Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.
Looking for a new role in 2025? We have a variety of roles currently open!
Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.
These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.
On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.
Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.
“MDPI thrives because of community and collaboration”
When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.
As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.
Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.
PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.
Impactful Research
685 MDPI Editors Named Highly Cited Researchers in 2024
I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.
Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.
Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.
As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.
I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.
Inside MDPI
How MDPI / Open Access Supports Societies
MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.
Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.
Learn about how MDPI / Open Access Supports Societies.
In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.
If you would like to learn more about these services, please see the Societies website.
The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.
How long have you been at MDPI, and what was your first role?
I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team.
Do you think that perceptions of Open Access are generally accurate?
Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards.
How long have you been at MDPI, and what was your first role?
I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.
What is the most common question you get asked about the services that the Societies team provides?
For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.
For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.
Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.
Read more:
Coming Together for Science
2024 MDPI Conference Summary
Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.
The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.
2024 Event Highlights
Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.
Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’
Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’
A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.
The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.
ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.
The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.
Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.
In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.
The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.
Scheduled Events in 2025
- Smart Sustainable Cities 2025: Pioneering Novel Frontiers for Green Urban Living: 5–7 Mar 2025, online.
- International Conference on Advanced Remote Sensing (ICARS 2025): 26–28 Mar 2025, Barcelona, Spain.
- Plants 2025: From Seeds to Food Security: 31 Mar–2 Apr 2025, Barcelona, Spain.
- Symmetry 2025 - The 5th International Conference on Symmetry: 16–19 May 2025, Hangzhou, China.
- The 2nd International Conference on AI Sensors and Transducers: 29 Jul–3 Aug 2025, Bangkok, Thailand.
- The 5th International Symposium on Frontiers in Molecular Science: 26–29 Aug 2025, Kyoto, Japan.
- The 11th World Sustainability Forum: Sustainable and Resilient Cities: 2–3 Oct 2025, Barcelona, Spain.
- The Cancers 2025 and Sensors 2025 websites will soon be made public.
Closing Thoughts
Over 100 German Universities Partner with MDPI in New National Agreement
I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.
This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.
Learn more, here.
“Thank you to everyone who contributed to making this agreement a reality.”
Why is this important?
Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.
This agreement reflects our growing influence and leadership in open access publishing.
Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.
As Peter Roth, MDPI Head of Publishing, noted:
“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.”
Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:
“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform”
Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.
Chief Executive Officer
MDPI AG
26 December 2024
Meet Us at the 5th SPLC-CRS Young Scientists Meeting, 30–31 January 2025, Barcelona, Spain
20 December 2024
Pharmaceuticals | Pharmaceuticals 2024—Recent Advances in Pharmaceutical Sciences Towards a Healthy Life Conference Held
We are pleased to share the success of our MDPI conference. The 1st physical conference Pharmaceuticals 2024—Recent Advances in Pharmaceutical Sciences Towards a Healthy Life was held in Barcelona, Spain, from 27 to 29 November 2024. It was chaired by Prof. Dr. Amelia Pilar Rauter from the Universidade de Lisboa, Portugal; Dr. Alfredo Berzal Herranz from Instituto de Parasitología y Biomedicina López-Neyra (IPBLN) CSIC, Spain; and Prof. Dr. Mary Jane Meegan from Trinity College Dublin, Ireland.
Prof. Dr. Amelia Pilar Rauter (Editor-in-Chief ) during the opening ceremony
The event was jointly organized by the MDPI conference team and the journal Pharmaceuticals (ISSN: 1424-8247), with support from the Spanish Society Of Medicinal Chemistry (SEQT) and the Spanish Society For Biochemistry And Molecular Biology (SEBBM).
Covering, among others, the newest technologies and research areas in medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, this conference brought together experts to present their latest findings on combatting infection, inflammation, pain, and neurodegeneration, to cite only some of the relevant topics that were discussed.
We accepted a total of 95 abstracts, featuring 64 authors from 28 countries. Over the course of the three-day event, 32 posters were displayed and 29 talks were delivered, including 3 plenary talks, 8 invited talks, and 29 selected oral presentations.
Moreover, we are pleased to announce the winners of the two awards, including Best Presentation and Best Poster, recognizing the contributions of our participants during the conference.
We would like to highlight that the participants of this conference can submit their work to the Special Issue “Pharmaceuticals 2024—Recent Advances in Pharmaceutical Sciences Towards a Healthy Life” edited by Prof. Dr. Amélia Pilar Rauter, Dr. Alfredo Berzal-Herranz, and Prof. Dr. Mary J. Meegan in the Pharmaceuticals journal.
Symposium participants, as well as all researchers working in the field, are cordially invited to contribute original research papers or reviews to this Special Issue of Pharmaceuticals. You can find more information at the following link https://www.mdpi.com/journal/pharmaceuticals/special_issues/JRUAJS5B2I.
The Pharmaceuticals conference has established itself as a leading event in the field of pharmaceuticals for researchers worldwide. We look forward to the next edition of Pharmaceuticals 2026!
17 December 2024
Over 100 German Universities Partner with MDPI in New National Agreement
More than 100 German universities and research institutions have entered into a national agreement with MDPI. The publication agreement negotiated by ZB MED comes into effect on 1 January 2025 and is valid until the end of 2026. Joining the consortium is still possible until the beginning of 2025. We are delighted by the high level of interest this agreement has already garnered, reflecting the strong demand for accessible and cost-effective open access publishing solutions among German research institutions.
This new cooperation aims to make scientific gold open access publishing more affordable and less administratively burdensome for researchers in Germany. The agreement includes substantial discounts on article processing charges (APCs) for corresponding authors from participating institutions. It offers flexible payment options, including centralized invoicing or individual payment of fees by researchers or their institutions. Additionally, the agreement features a flat-fee model that enables institutions to precisely plan expenses and optimize their library budgets.
"MDPI can look back on over a decade of successful partnerships with German research institutions," says Peter Roth, MDPI Head of Publishing. "The new agreement marks another milestone in the long-standing co-operation between MDPI and the German scientific community. It emphasizes our commitment to developing up-to-date and inventive solutions for the diverse needs of scientific institutions to promote open research for the benefit of researchers."
Petra Labriga, Head of Strategic License Management at ZB MED, highlighted the agreement's significance: "As one of the world's leading Gold OA publishers, MDPI plays a central role in the German publishing landscape. We are particularly pleased that we were able to achieve considerable potential cost savings for scientific institutions and their authors at a national level through our negotiations."
The partnership reflects a common goal of advancing the idea of open access and supporting researchers in making their scientific excellence internationally visible.
"We would like to thank the ZB MED consortium team for their excellent collaboration," added Adrian Stefan Zamfir, MDPI Institutional Partnership Manager for the DACH region. "We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform."
Franziska Fischer (right), Commercial Director at ZB MED, an Peter Roth (left), Head of Publishing at MDPI, celebrate the signing of the new national open access agreement between MDPI and the ZB MED Consortium.
More Information
Contact
- ZB MED: Team Konsortiallizenzen ([email protected]) - Website
MDPI: Adrian Stefan Zamfir, Institutional Partnership Manager ([email protected])
About ZB MED
ZB MED - Information Centre for Life Sciences is an infrastructure and research centre for life science information and data. Its aim is to support and strengthen research for people and the environment: from medicine to biodiversity and environmental protection.
The work of ZB MED is orientated towards the strategic guidelines:
- Research + Networking: We conduct research together with the regionally, nationally, European and globally networked research community.
- Data science: We enable data analyses and generate new knowledge through research.
- Access to information: We provide sustainable access to information, literature and data as a central information infrastructure.
- Open + FAIR: We promote open and reproducible science in line with open science and FAIR principles.
- Knowledge and skills transfer: We actively impart knowledge, competences and skills.
More information at www.zbmed.de.
About MDPI
Headquartered in Basel, Switzerland, MDPI is one of the world's leading open access publishers with a current portfolio of more than 440 journals in all scientific disciplines. MDPI‘s goal is to advance open science worldwide through greater transparency, efficiency and collaboration. To date, more than 3.7 million researchers have published their results in MDPI journals. The editorial process is overseen by a large network of dedicated reviewers and editors and supported by more than 6500 MDPI employees. MDPI currently works with over 800 academic institutions and 180 scientific societies worldwide, which benefit from a wide range of MDPI services and products.
17 December 2024
Article Layout and Template Revised for Future Volumes
16 December 2024
Recruiting Editorial Board Members for Pharmaceuticals
